GlassScriptPhysician profile
Beverly A Lang
NPI 1366680522
$1,425.47
in general payments reported to CMS, 2019-2025
13 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $372 · 2022: $581 · 2023: $90.25 · 2024: $274 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $214.77 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.51 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $127.47 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $121.84 | 2024 | Austedo Xr |
| Biogen, INC. | $105.12 | 2022 | |
| Corcept Therapeutics | $102.11 | 2021 | |
| Neurocrine Biosciences, INC. | $101.67 | 2022 | |
| Gilead Sciences, INC. | $100.00 | 2022 | |
| Emd Serono, INC. | $90.25 | 2023 | |
| Nevro Corp. | $84.90 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $81.05 | 2021 | |
| Sanofi Pasteur INC. | $72.85 | 2022 | |
| Abbvie INC. | $24.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.